Abstract:Expression of recombinant proteins in Escherichia coli often requires use of inducible promoters to shorten the lag phase and improve protein productivity and final protein titer. Synthetic molecules that cannot be metabolized by E. coli, such as isopropyl thiogalactopyranoside (IPTG), have been frequently used to trigger the protein expression during early exponential growth phase. This practice has many drawbacks, including high cost and toxicity of IPTG, complex operating procedure, and non-uniform protein expression pattern (some cells in the population do not express recombinant proteins). A few auto-inducible protein expression systems have been developed recently to overcome some of these limitations, but they required use of an additional plasmid or presence of large (a few kilobases) DNA part to be functional, making plasmid construction to be difficult, especially when multiple genes need to be expressed. In this study, by using RNA sequencing, we identified a short, endogenous promoter (PthrC) that can be auto-induced during early exponential growth phase, and improved its performance by use of native and mutated regulatory elements. We found that the developed mutants of PthrC drove uniform protein expression—close to 100% of cells were fluorescent when green fluorescence protein was used as target protein—and cells carrying them could achieve much higher cell density than those with T7 promoter (PT7), a commonly used inducible promoter. In terms of promoter strength (product protein quantity per cell), the developed promoter mutants can cover a range of strength, from 30 to 150% of maximal strength of PT7. One strong mutant (PthrC3_8) was found to work well at a large range of temperature (22, 30, 37 °C) and in various media, and was also confirmed to cause less stress to host cell than PT7 when they were used to express a toxic protein. We foresee that PthrC3 and its mutants will be useful genetic parts for various applications including metabolic engineering and biocatalysis.

Mammalian ubiquitous promoter isolated from proximal regulatory region of bovine MSTN gene

A novel promoterless gene targeting vector to efficiently disrupt PRNP gene in cattle.

An evolutionarily conserved Myostatin proximal promoter/enhancer confers basal levels of transcription and spatial specificity in vivo

A novel application of baculovirus in mammalian gene therapy]

Promoter Analysis of Bombyx Mori Nucleopolyhedrovirus Ubiquitin Gene.

A Vigna radiata 8S globulin α' promoter drives efficient expression of GUS in Arabidopsis cotyledonary embryos.

New function of a well‐known promoter: Enhancer activity of minimal CMV promoter enables efficient dual‐cassette transgene expression

Novel strong tissue specific promoter for gene expression in human germ cells

Transcription initiation mapping in 31 bovine tissues reveals complex promoter activity, pervasive transcription, and tissue-specific promoter usage

Characterization of upstream sequences from the 8S globulin gene of Vigna radiata

Controlling AOX1 promoter strength in Pichia pastoris by manipulating poly (dA:dT) tracts

Enhancement Of Biodemulsifier Produced By Alkaliphilic Alcali-Genes Sp S-Xj-1 By Ph Optimization And Waste Edible Oil Supplementation Strategy

CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation

A hybrid promoter-containing vector for direct cloning and enhanced expression of PCR-amplified ORFs in mammalian cells

Short, auto-inducible promoters for well-controlled protein expression in Escherichia coli

Dramatic Increase in Expression of a Transgene by Insertion of Promoters Downstream of the Cargo Gene

New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina

Establishment of a new promoter trapping vector using 2A peptide

Proteomic Studies on the Mechanism of Myostatin Regulating Cattle Skeletal Muscle Development

A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann–Pick Type C1 Disease

308 DEVELOPMENT OF TRANSGENIC LIVESTOCK WITH REDUCED MYOSTATIN EXPRESSION USING RNA INTERFERENCE